These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Adverse reactions to alcuronium. An Australian disease? Fisher M; Baldo B Med J Aust; 1983 Jun; 1(13):630-2. PubMed ID: 6855688 [No Abstract] [Full Text] [Related]
23. [Alcuronium (clinical experience with about 500 cases)]. Cristea H; Litarczek G; Darutzi A; Benţia L; Ghiga AR Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1974; 23(7):641-8. PubMed ID: 4283140 [No Abstract] [Full Text] [Related]
24. Severe bronchospasm in an asthmatic patient following alcuronium and D-tubocurarine. Yeung ML; Ng LY; Koo AW Anaesth Intensive Care; 1979 Feb; 7(1):62-4. PubMed ID: 434447 [TBL] [Abstract][Full Text] [Related]
25. Intubating conditions following pre-induction priming with alcuronium. Harrop-Griffiths AW; Grounds RM; Moore M Anaesthesia; 1986 Mar; 41(3):282-6. PubMed ID: 3963331 [TBL] [Abstract][Full Text] [Related]
27. [Dosage of diallyl-nor-toxiferine calculated on the basis of lean body mass]. Yamayoshi S; Yoshikawa K; Kawai T Masui; 1976 Feb; 25(2):120-6. PubMed ID: 943596 [No Abstract] [Full Text] [Related]
28. Quantification of pravastatin in human plasma and urine after solid phase extraction using high performance liquid chromatography with ultraviolet detection. Bauer S; Mwinyi J; Stoeckle A; Gerloff T; Roots I J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(2):257-62. PubMed ID: 15734167 [TBL] [Abstract][Full Text] [Related]
29. [Radioimmunoassay method for the detection of IgE antibodies specific to alcuronium]. Guéant JL; Kamel L; Moneret-Vautrin DA; Widmer S; Laxenaire MC; Nicolas JP Ann Fr Anesth Reanim; 1986; 5(6):570-3. PubMed ID: 3826789 [TBL] [Abstract][Full Text] [Related]
30. A double-blind clinical trial comparing alcuronium with pancuronium. Schivute M; Ertama P; Mattila MA Acta Anaesthesiol Belg; 1982; 33(1):23-31. PubMed ID: 7046331 [TBL] [Abstract][Full Text] [Related]
32. Adverse reactions to atracurium and alcuronium. A prospective surveillance study. Beemer GH; Dennis WL; Platt PR; Bjorksten AR; Carr AB Br J Anaesth; 1988 Dec; 61(6):680-4. PubMed ID: 2974714 [TBL] [Abstract][Full Text] [Related]
33. Prolonged paralysis following an infusion of alcuronium in a patient with renal dysfunction. Smith CL; Hunter JM; Jones RS Anaesthesia; 1987 May; 42(5):522-5. PubMed ID: 3592179 [TBL] [Abstract][Full Text] [Related]
34. Letter: anaesthesia in a patient with previous malignant hyperpyrexia. Judelman H; Pirie DH Br J Anaesth; 1974 Jul; 46(7):519. PubMed ID: 4458772 [No Abstract] [Full Text] [Related]
38. Committee on Safety of Medicines. Scowen E Br J Anaesth; 1978 Dec; 50(12):1270. PubMed ID: 747705 [No Abstract] [Full Text] [Related]
39. A new method for determination of buformin in plasma and urine by ion-paired reversed-phase HPLC with ultraviolet detection. Yamamoto T; Kusama M; Matsuno K; Sugiyama E; Yamada Y; Iga T Biomed Chromatogr; 2002 Oct; 16(7):453-4. PubMed ID: 12378556 [TBL] [Abstract][Full Text] [Related]
40. Determination of the antiangiogenesis agent 2-methoxyestradiol in human plasma by liquid chromatography with ultraviolet detection. Lakhani NJ; Sparreboom A; Dahut WL; Venitz J; Figg WD J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jul; 806(2):289-93. PubMed ID: 15171941 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]